SECURITIES AND EXCHANGE COMMISSION
                              Washington, DC 20549

                                    FORM 8-K

                                 CURRENT REPORT

     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

      Date of Report (Date of earliest event reported): July 16, 2005


                       MEDSTRONG INTERNATIONAL CORPORATION
--------------------------------------------------------------------------------
               (Exact Name of Registrant as Specified in Charter)


          Delaware                     000-33035             95-4855709
----------------------------- ----------------------- -----------------------
(State or Other Jurisdiction         (Commission           (I.R.S. Employer
     of Incorporation)               File Number)         Identification No.)


        350 Bedford Street, Suite 203, Stamford, CT        06901
--------------------------------------------------------------------------------
          (Address of Principal Executive Offices)      (Zip Code)


       Registrant's telephone number, including area code: (203) 352-8800


--------------------------------------------------------------------------------
          Former name or former address, if changed since last report

Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):

{ } Written communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425)

{ } Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a -12)

{ } Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
Act (17 CFR 240.14d -2(b))

{ } Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
Act (17 CFR 240.13e -4(c))

-----------------------------------------------------------------------------

<PAGE>

Item 4.01.  Change in Registrant's Certifying Accountant.


      On July 16, 2005, Medstrong International Corporation's ("we" or the
"Company") Board of Directors was informed that the Company's independent
auditors, Weinick Sanders Leventhal & Co., LLP ("WSL"), which had audited the
Company's financial statements for the last three fiscal years ended December
31, 2004, 2003, and 2002, respectively, will cease to perform audit services for
publicly held entities on or about August 1, 2005 and sometime thereafter WSL
will be dissolved.

      None of WSL's reports on the Company's financial statements for
any of the Company's past two fiscal years contained an adverse opinion or
disclaimer of opinion, or was qualified or modified as to uncertainty, audit
scope, or accounting principles, except for a modification as to an uncertainty
about the Company's ability to continue as a going concern. During the Company's
two most recent fiscal years and any subsequent interim period preceding the
resignation of WSL, there were no disagreements with WSL on any matter of
accounting principles or practices, financial statement disclosure, or auditing
scope or procedure, which disagreement(s), if not resolved to the satisfaction
of WSL, would have caused it to make a reference to the subject matter of the
disagreement(s) in connection with its report. There were no "reportable events"
(as defined in Item 304(a)(v) of Regulation S-K) that occurred within the
Company's two most recent fiscal years.

Item 9.01. Financial Statements and Exhibits.

(c) Exhibits.

         Exhibit No.                       Description
         -----------                       -----------

         16.1     Letter on change in certifying accountant from Weinick Sanders
                  Leventhal & Co., LLP


<PAGE>

                                    SIGNATURE

      Pursuant to the requirements of the Securities Exchange Act of 1934, the
Company has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.

                                MEDSTRONG INTERNATIONAL CORPORATION


                                By /s/ Jeanine Folz
                                   ------------------------------
                                   Jeanine Marie Folz, Chief Executive
                                   and Principal Financial Officer

Date: July 26, 2005
{"company-data": {"conformed-name": "MEDSTRONG INTERNATIONAL CORP", "cik": "0001136711", "assigned-sic": "7389", "irs-number": "954855709"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-33035", "film-number": "05974117"}, "business-address": {"street1": "500 SILVER SPUR ROAD SUITE 303", "city": "RANCHO PALOS VERDES", "state": "CA", "zip": "90274"}, "mail-address": {"street1": "500 SILVER SPUR ROAD SUSITE 303", "city": "RANCHO PALOS VERDES", "state": "CA", "zip": "90274"}}
SECURITIES AND EXCHANGE COMMISSION
                              Washington, DC 20549

                                    FORM 8-K

                                 CURRENT REPORT

     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

      Date of Report (Date of earliest event reported): July 16, 2005

                       MEDSTRONG INTERNATIONAL CORPORATION
--------------------------------------------------------------------------------
               (Exact Name of Registrant as Specified in Charter)

          Delaware                     000-33035             95-4855709
----------------------------- ----------------------- -----------------------
(State or Other Jurisdiction         (Commission           (I.R.S. Employer
     of Incorporation)               File Number)         Identification No.)

        350 Bedford Street, Suite 203, Stamford, CT        06901
--------------------------------------------------------------------------------
          (Address of Principal Executive Offices)      (Zip Code)

       Registrant's telephone number, including area code: (203) 352-8800

--------------------------------------------------------------------------------
          Former name or former address, if changed since last report

Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):

{ } Written communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425)

{ } Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a -12)

{ } Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
Act (17 CFR 240.14d -2(b))

{ } Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
Act (17 CFR 240.13e -4(c))

-----------------------------------------------------------------------------
Item 4.01.  Change in Registrant's Certifying Accountant.

      On July 16, 2005, Medstrong International Corporation's ("we" or the
"Company") Board of Directors was informed that the Company's independent
auditors, Weinick Sanders Leventhal & Co., LLP ("WSL"), which had audited the
Company's financial statements for the last three fiscal years ended December
31, 2004, 2003, and 2002, respectively, will cease to perform audit services for
publicly held entities on or about August 1, 2005 and sometime thereafter WSL
will be dissolved.

      None of WSL's reports on the Company's financial statements for
any of the Company's past two fiscal years contained an adverse opinion or
disclaimer of opinion, or was qualified or modified as to uncertainty, audit
scope, or accounting principles, except for a modification as to an uncertainty
about the Company's ability to continue as a going concern. During the Company's
two most recent fiscal years and any subsequent interim period preceding the
resignation of WSL, there were no disagreements with WSL on any matter of
accounting principles or practices, financial statement disclosure, or auditing
scope or procedure, which disagreement(s), if not resolved to the satisfaction
of WSL, would have caused it to make a reference to the subject matter of the
disagreement(s) in connection with its report. There were no "reportable events"
(as defined in Item 304(a)(v) of Regulation S-K) that occurred within the
Company's two most recent fiscal years.

Item 9.01. Financial Statements and Exhibits.

(c) Exhibits.

         Exhibit No.                       Description
         -----------                       -----------

         16.1     Letter on change in certifying accountant from Weinick Sanders
                  Leventhal & Co., LLP
SIGNATURE

      Pursuant to the requirements of the Securities Exchange Act of 1934, the
Company has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.

                                MEDSTRONG INTERNATIONAL CORPORATION

                                By /s/ Jeanine Folz
                                   ------------------------------
                                   Jeanine Marie Folz, Chief Executive
                                   and Principal Financial Officer

Date: July 26, 2005